Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Challenge of phenotype estimation for optimal treatment of Krabbe disease.
Is disability measured by FIM a predictor for successful self-intermittent catheterization in neurological patients?
A multi-biomarker follow-up study of patients with multiple sclerosis.
Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases.
Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.
Laquinimod prevents cuprizone-induced demyelination independent of Toll-like receptor signaling.
Blood-Spinal Cord Barrier Alterations in Subacute and Chronic Stages of a Rat Model of Focal Cerebral Ischemia.
Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study.
Is cell migration or proliferation dominant in the formation of linear arrays of oligodendrocytes?
Multiple sclerosis: Dimethyl fumarate is coming of age.
Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens.
mRNA expression profile of mouse oligodendrocytes in inflammatory conditions.
Application of Item Response Theory to Modeling of Expanded Disability Status Scale in Multiple Sclerosis.
Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.
Depiction of dentatorubrothalamic tract fibers in patients with Parkinson's disease and multiple sclerosis in deep brain stimulation.
Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia.
Babesia parasitemia rebound after red blood cell exchange.
Follow-up of hypertension in patients with multiple sclerosis.
Basic Approaches In Therapy Of Multiple Sclerosis (MS) And Related Diseases: Current Acchievements And Prospective.
Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.
Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis.
Effects of a home-based upper-limb training program in patients with Multiple Sclerosis: a randomized controlled trial.
Need for symptomatic management in advanced multiple sclerosis.
Pages
« first
‹ previous
…
772
773
774
775
776
777
778
779
780
…
next ›
last »